Synthesis of ( Z )- N -hydroxy-3-methoxy-3-phenylacrylamide as new selective inhibitor of hepatitis C virus replication

M. V. Kozlov; A. A. Kleymenova; K. A. Konduktorov; A. Z. Malikova; K. A. Kamarova; R. A. Novikov; S. N. Kochetkov

doi:10.1134/S1068162016010076

Synthesis of (Z)-N-hydroxy-3-methoxy-3-phenylacrylamide as new selective inhibitor of hepatitis C virus replication

Авторлар: Kozlov M.¹, Kleymenova A.¹, Konduktorov K.¹, Malikova A.¹, Kamarova K.¹, Novikov R.¹, Kochetkov S.¹
Мекемелер:
1. Engelhardt Institute of Molecular Biology
Шығарылым: Том 42, № 2 (2016)
Беттер: 191-197
Бөлім: Article
URL: https://journals.rcsi.science/1068-1620/article/view/227875
DOI: https://doi.org/10.1134/S1068162016010076
ID: 227875

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат
Рұқсат жабық

Рұқсат берілді
Рұқсат жабық

Тек жазылушылар үшін

Аннотация
Авторлар туралы
Әдебиет тізімі
Статистика

Аннотация

According to recently published results, cinnamic hydroxamic acid (CHA) inhibits replication of hepatitis C virus (HCV). We synthesized a structural analogue of CHA, i.e., (Z)-N-hydroxy-3-methoxy3-phenylacrylamide, which inhibited HCV replication five times more selectively than CHA. It was found that both compounds did not inhibit deacetylation of Ac-α-tubulin with histone deacetylase 6, the activity of which is important for virus replication.